These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 12112404
1. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Pickel VM, Chan J, Nirenberg MJ. Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404 [Abstract] [Full Text] [Related]
2. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC. J Comp Neurol; 2004 May 17; 473(1):97-106. PubMed ID: 15067721 [Abstract] [Full Text] [Related]
3. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. J Neurosci; 1996 Jul 01; 16(13):4135-45. PubMed ID: 8753875 [Abstract] [Full Text] [Related]
4. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area. Lessard A, Grady EF, Bunnett NW, Pickel VM. Neuroscience; 2007 Feb 23; 144(4):1393-408. PubMed ID: 17197098 [Abstract] [Full Text] [Related]
5. Mu-opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons. Svingos AL, Garzón M, Colago EE, Pickel VM. Synapse; 2001 Sep 01; 41(3):221-9. PubMed ID: 11418935 [Abstract] [Full Text] [Related]
6. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals. Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM. Synapse; 1997 Jun 01; 26(2):194-8. PubMed ID: 9131778 [Abstract] [Full Text] [Related]
7. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Murer MG, Dziewczapolski G, Menalled LB, García MC, Agid Y, Gershanik O, Raisman-Vozari R. Ann Neurol; 1998 May 01; 43(5):561-75. PubMed ID: 9585350 [Abstract] [Full Text] [Related]
8. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron. Pickel VM, Garzón M, Mengual E. Prog Brain Res; 2002 May 01; 136():145-55. PubMed ID: 12143378 [Abstract] [Full Text] [Related]
9. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M. J Comp Neurol; 2004 Nov 08; 479(2):198-215. PubMed ID: 15452855 [Abstract] [Full Text] [Related]
10. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Suzuki M, Desmond TJ, Albin RL, Frey KA. Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403 [Abstract] [Full Text] [Related]
11. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Carr DB, Sesack SR. Synapse; 2000 Nov 15; 38(2):114-23. PubMed ID: 11018785 [Abstract] [Full Text] [Related]
12. Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Garzón M, Pickel VM. Synapse; 2001 Sep 15; 41(4):311-28. PubMed ID: 11494402 [Abstract] [Full Text] [Related]
13. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. J Comp Neurol; 1997 Nov 17; 388(2):211-27. PubMed ID: 9368838 [Abstract] [Full Text] [Related]
14. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell. Delle Donne KT, Chan J, Boudin H, Pélaprat D, Rostène W, Pickel VM. Synapse; 2004 Jun 01; 52(3):176-87. PubMed ID: 15065218 [Abstract] [Full Text] [Related]
15. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK. J Pharmacol Exp Ther; 2000 May 01; 293(2):329-35. PubMed ID: 10772999 [Abstract] [Full Text] [Related]
16. Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Mengual E, Pickel VM. Synapse; 2002 Mar 01; 43(3):151-62. PubMed ID: 11793420 [Abstract] [Full Text] [Related]
17. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG, Sonsalla PK. J Pharmacol Exp Ther; 2000 May 01; 293(2):336-42. PubMed ID: 10773000 [Abstract] [Full Text] [Related]
18. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Adell A, Artigas F. Neurosci Biobehav Rev; 2004 Jul 01; 28(4):415-31. PubMed ID: 15289006 [Abstract] [Full Text] [Related]
19. Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area. Garzón M, Duffy AM, Chan J, Lynch MK, Mackie K, Pickel VM. Neuroscience; 2013 Nov 12; 252():126-43. PubMed ID: 23954803 [Abstract] [Full Text] [Related]
20. Transient developmental expression of monoamine transporters in the rodent forebrain. Lebrand C, Cases O, Wehrlé R, Blakely RD, Edwards RH, Gaspar P. J Comp Neurol; 1998 Nov 30; 401(4):506-24. PubMed ID: 9826275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]